Search

Search Constraints

You searched for: Author/Creator Stieglitz, Elliot

Search Results

4. Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. (December 2022)

5. MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus. Issue 11 (5th July 2022)

6. Therapy‐related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literature. Issue 5 (22nd December 2021)

7. Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Issue 7 (12th March 2018)

9. Phase II/III trial of a pre‐transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: A report from the Children's Oncology Group. Issue 4 (8th December 2014)

10. NUP98-NSD1 Driven MDS/MPN in Childhood Masquerading as JMML. Issue 6 (August 2021)